Skip to main content

Table 1 Clinicopathological data of patients with NMIBC

From: Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing

Clinicopathological variants BCG group (n = 46) EPI group (n = 12) Total (n = 58) P-value
Gender     0.432
 Male 35 11 46  
 Female 11 1 12  
Preoperative age (years)     0.336
 ≤ 60 18 7 25  
 60–70 19 4 23  
 > 70 9 1 10  
Smoking history     0.331
 No 25 4 29  
 Yes 21 8 29  
Prior recurrence rate     0.233
 Primary 27 5 32  
 Recurrent, ≤ 1 rec/year 11 2 13  
 Recurrent, > 1 rec/year 8 5 13  
T category     0.012
 Ta 29 12 41  
 T1 17 0 17  
Grade     0.331
 Low grade 21 8 29  
 High grade 25 4 29  
Tumor size (cm)     0.759
 < 3 26 8 34  
 ≥ 3 20 4 24  
No. tumors     0.891
 ≤ 3 34 8 42  
 > 3 12 4 16  
Risk stage     0.291
 Intermediate risk 19 5 26  
 High risk 27 5 32  
EORTC risk tables     0.956
 1–4 17 3 20  
 5–9 24 9 33  
 10–17 5 0 5  
CUETO scoring model     0. 866
 0–4 13 3 16  
 5–6 16 5 21  
 7–9 15 4 19  
 10–16 2 0 2  
  1. NMIBC: non-muscle invasive bladder cancer; n: number of patients; No: number; Recurrent, ≤ 1 rec/year: prior recurrence rate of less than one per year; Recurrent, > 1 rec/year: prior recurrence rate of more than one per year; EORTC: European Organization for Research and Treatment of Cancer; CUETO: Spanish Urological Club for Oncological Treatment